Hanall Biopharma Market Cap

Hanall Biopharma has a market cap or net worth of 2.1 trillion as of May 18, 2026. Its market cap has increased by 52.23% in one year.

Market Cap

2.10T

Enterprise Value

2.11T

Revenue

155.18B

Ranking

n/a

PE Ratio

n/a

Stock Price

39,250.00

Market Cap Chart

Since August 30, 1995, Hanall Biopharma's market cap has increased from 26.30B to 2.10T, an increase of 7,903.50%. That is a compound annual growth rate of 15.32%.

Market Cap History

Date	Market Cap	% Change
May 18, 2026	2.10T	-5.26%
Dec 30, 2025	2.22T	13.35%
Dec 30, 2024	1.96T	-12.72%
Dec 28, 2023	2.25T	148.89%
Dec 29, 2022	902.29B	-16.29%
Dec 30, 2021	1.08T	-43.84%
Dec 30, 2020	Upgrade Pro	Upgrade Pro
Dec 30, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 28, 2017	Upgrade Pro	Upgrade Pro
Dec 29, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Yuhan	6.39T
Hanmi Pharm.	5.99T
Celltrion Pharm	2.32T
Daewoong Pharmaceutical	1.63T
GC Biopharma	1.58T
Chong Kun Dang Pharmaceutical	1.07T
DongKook Pharmaceutical	1.02T
Daewoong	862.79B

Market Cap Rankings